Trial Profile
A phase I study of GLPG2851 in healthy volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Jan 2018
Price :
$35
*
At a glance
- Drugs GLPG 2851 (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions; First in man; Pharmacokinetics
- 05 Jan 2018 New trial record
- 02 Jan 2018 According to a Galapagos NV media release, topline results from this trial are expected to be disclosed at a future medical conference.